• linkedin
  • Increase Font
  • Sharebar

    Oral options not keeping up with biologics

    In a study published online February 3, 2015 in Expert Opinion on Emerging Drugs, researchers analyzed emerging oral drugs for psoriasis and concluded “… the development of new oral treatments for moderate-to-severe psoriasis has not kept pace with biologic therapies. There continues to be a need for safe and effective long-term oral therapies.”

    Researchers reviewed oral treatments for moderate to severe psoriasis, including methotrexate, acitretin, cyclosporine and apremilast.

    Reference

    Mahmood T, Zaghi D, Menter A. Emerging oral drugs for psoriasis. Expert Opin Emerg Drugs. 2015;1-12. [Epub ahead of print]

     

    Lisette Hilton
    Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available
    Derm Pulse
    Article image

    ©TED

    Brought to you by:

    Ortho Derm

    Latest Tweets Follow